184 related articles for article (PubMed ID: 16201949)
21. [Molecular targeting therapy for multiple myeloma].
Takatoku M
Nihon Rinsho; 2007 Dec; 65(12):2345-50. PubMed ID: 18069281
[TBL] [Abstract][Full Text] [Related]
22. The emerging role of novel therapies for the treatment of relapsed myeloma.
Richardson PG; Hideshima T; Mitsiades C; Anderson KC
J Natl Compr Canc Netw; 2007 Feb; 5(2):149-62. PubMed ID: 17335684
[TBL] [Abstract][Full Text] [Related]
23. New treatment approaches in multiple myeloma.
Berrebi A
Isr Med Assoc J; 2005 Dec; 7(12):820-1. PubMed ID: 16382710
[No Abstract] [Full Text] [Related]
24. Targeted therapy of multiple myeloma.
Kyle RA
Hematology; 2012 Apr; 17 Suppl 1():S125-8. PubMed ID: 22507799
[TBL] [Abstract][Full Text] [Related]
25. Maintenance treatment in multiple myeloma.
Harousseau JL
Ann Oncol; 2008 Jun; 19 Suppl 4():iv54-5. PubMed ID: 18519405
[No Abstract] [Full Text] [Related]
26. High-dose therapy and immunomodulatory drugs in multiple myeloma.
Barlogie B; Shaughnessy J; Zangari M; Tricot G
Semin Oncol; 2002 Dec; 29(6 Suppl 17):26-33. PubMed ID: 12520482
[TBL] [Abstract][Full Text] [Related]
27. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival.
Palumbo A; Attal M; Roussel M
Clin Cancer Res; 2011 Mar; 17(6):1253-63. PubMed ID: 21411441
[TBL] [Abstract][Full Text] [Related]
28. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH
Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and the current trends in multiple myeloma therapy.
Dmoszyńska A
Pol Arch Med Wewn; 2008 Oct; 118(10):563-6. PubMed ID: 19112817
[TBL] [Abstract][Full Text] [Related]
30. Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
Caballero-Velázquez T; López-Corral L; Encinas C; Castilla-Llorente C; Martino R; Rosiñol L; Sampol A; Caballero D; Serrano D; Heras I; San Miguel J; Pérez-Simón JA
Br J Haematol; 2013 Aug; 162(4):474-82. PubMed ID: 23772672
[TBL] [Abstract][Full Text] [Related]
31. Myeloma: making sense of a complex blood cancer.
Kelly MB; Meenaghan T; Dowling M
Br J Nurs; 2010 Dec 9-2011 Jan 13; 19(22):1415-21. PubMed ID: 21139523
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in myeloma treatment.
Schots R
Transfus Apher Sci; 2011 Apr; 44(2):223-9. PubMed ID: 21349768
[TBL] [Abstract][Full Text] [Related]
33. New drugs for myeloma.
Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
[TBL] [Abstract][Full Text] [Related]
34. Current treatment options for myeloma.
Terpos E; Rahemtulla A; Dimopoulos MA
Expert Opin Pharmacother; 2005 Jun; 6(7):1127-42. PubMed ID: 15957967
[TBL] [Abstract][Full Text] [Related]
35. [Molecular-targeted therapy of multiple myeloma].
Iida S
Nihon Naika Gakkai Zasshi; 2010 Jan; 99(1):132-9. PubMed ID: 20376958
[No Abstract] [Full Text] [Related]
36. Frontline treatment of multiple myeloma.
Fonseca R
Hematology; 2012 Apr; 17 Suppl 1():S101-4. PubMed ID: 22507793
[TBL] [Abstract][Full Text] [Related]
37. Treatment of multiple myeloma: 2009 update.
Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
[TBL] [Abstract][Full Text] [Related]
38. [New treatment strategy of multiple myeloma for cure].
Murakami H; Handa H
Gan To Kagaku Ryoho; 2006 Apr; 33(4):417-23. PubMed ID: 16612147
[TBL] [Abstract][Full Text] [Related]
39. Thalidomide and CC-5013 in multiple myeloma: the University of Arkansas experience.
Barlogie B
Semin Hematol; 2003 Oct; 40(4 Suppl 4):33-8. PubMed ID: 15015894
[TBL] [Abstract][Full Text] [Related]
40. [Multiple myeloma].
Abe M
Nihon Rinsho; 2009 May; 67(5):991-5. PubMed ID: 19432122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
